From two-scoop
start to a compounding
beverage system.

You built the product truth.
Now build the demand infrastructure.

Neural Scoops has real formulations, a clean-label position, and a founder-written content backbone. What it doesn't have yet is a system that routes strangers to that truth reliably — at a CAC the unit economics can carry.

Two protocols live: Dopamine & Energy and Daytime Allergy Support. Both sit at $34.99 with subscribe & save. There's a promo cadence, a Shopify storefront that converts, and a founder who ships every blog post himself. The bottleneck isn't the product. It isn't even the story. It's that every acquisition dollar today has to work harder than it should because the demand system underneath is doing most of its lifting by hand.

The recommendation: pick a single hero funnel (Dopamine & Energy as the flagship on-ramp), make the Allergy protocol the parallel wedge with its own dedicated angle bank, and build the retention spine (email + sub&save + a nudge-based renewal flow) so every acquired customer works twice. Free the founder from creative production so he can operate the brand instead of running it.

The same brand.
Different operating shape.

What a healthy nootropic-beverage system
looks like at ninety days.

Illustrative AYMI benchmarks from adjacent DTC engagements in functional beverage, hair/nail/skin subscription, and clean-label supplement. Every number gets calibrated against Neural Scoops' actual data during the scoping call.

Illustrative benchmarks based on adjacent AYMI DTC engagements. Actual targets set jointly during the scoping call once real CAC / AOV / retention numbers are on the table.

Different problems.
Same daily ritual.

Persona segmentation matters more here than in most DTC because Neural Scoops has two distinct symptom-led wedges (focus and allergy) that share one retention mechanic (the scoop). Each persona routes to a different lander, a different ad angle, and a different lifecycle track — then converges on the same subscribe & save.

The hero-funnel consolidation.

Two protocols is not "too many." Two homepage heroes competing for the same visitor's attention is. The fix is architecture, not amputation.

Dopamine & Energy becomes the flagship on-ramp. It's the broader-audience wedge, the one with the "no jitters / no crash" universal hook, and the one that most naturally leads to the daily-ritual position that carries subscribe & save. Allergy stays live at full weight — but on its own paid ad set, its own dedicated landing page, its own audience, its own retention track.

Then the third door: the Scoop Stack bundle route. Every retained customer eventually gets offered the second protocol. That's how a 2-SKU brand behaves like a 4-SKU brand without ever launching a new formula.

Creative cadence beats creative budget.

The "Function over Capsules" authority hub.

The retention spine.

Protocol-specific landers,
quiz-led router.

One dashboard.
One weekly decision.

Three shapes.
One recommendation.

Every AYMI engagement is monthly, no long-term lock. Media spend, software, and creator/influencer fees are pass-through and separate from the retainer. The middle tier is starred for most brands; the founder-led starter shape is where Neural Scoops most likely begins.

Start with Foundation.
Graduate on real data.

The signal from the quiz — pre-revenue or under $1M, budget under $50K/month, "CAC is too high" as the named bottleneck — points to Foundation as the honest starting shape. It gives Neural Scoops the strategist, the AI dashboard, the weekly creative cadence, the lifecycle build, and the CRO on the primary landers. That's the demand-infrastructure work that unlocks the next round of paid spend.

The graduation trigger to Growth System is objective: when the Foundation build has stabilized blended CAC below target and the brand is ready to test a second paid channel (Google search + Reels/TikTok) with real budget behind it, we step up. Not before.

What the first ninety days actually looks like.

Three brands that share the mechanical shape.

Every proof point below is a documented AYMI engagement. Metrics reflect actual outcomes, not projections. Case study links available on request.

Six things we want to hear from you.

• 01 · Real CAC and AOV baselineCurrent blended CAC across Meta + email, actual AOV, and repeat-purchase rate at 30/60/90 days. Lets us calibrate the benchmarks against reality.
• 02 · Subscribe & save active rateWhat percentage of orders are sub&save today, and what's the churn curve at month 2 and month 6? This tells us where the retention engine most needs work.
• 03 · The NeuralTrail questionThe About page references "NeuralTrail Electrolytes" as an earlier positioning. Is that a rebrand history, a parallel brand still active, or a naming inconsistency to clean up?
• 04 · Founder bandwidthHow much of your week is Neural Scoops today vs. USConnect? That governs the shape of the engagement — how much AYMI takes off your plate and where you stay hands-on.
• 05 · Product roadmapAre there additional protocols in the pipeline (Sleep? Immunity?), and if so, on what timeline? Affects how we build the hero-funnel architecture so it doesn't have to be rebuilt when SKU 3 lands.
• 06 · Budget shapeIs the <$50K/month declared on the quiz all-in (media + agency + tools), or is that the media envelope with the retainer separate? Governs which shape we recommend at the scoping call.